Plain-English translation of NCT07017179 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two experimental medications called and to see if they can safely help people with obesity or overweight lose weight. Researchers will study these medications given as injections—some participants will receive one medication alone, some will receive both together, and some will receive a placebo (a dummy injection) to compare results. The study focuses on people living in China and will track safety, side effects, how the body processes the medication, and whether it actually helps with weight loss.
Obesity and overweight are serious health challenges, and current weight loss options are limited. This trial exists to explore whether these new medications could offer patients a safe and effective treatment option.
You will receive injections either once or twice weekly (depending on which group you join) for 16 to 28 weeks. You'll make regular clinic visits for check-ups, blood tests, and measurements to monitor your weight and how your body is responding to the treatment. You may receive the actual medication or a placebo, and you won't know which one you're getting. After the treatment period ends, you'll have follow-up visits to make sure you're doing well.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
China